MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells
about
Induction of miR-137 by Isorhapontigenin (ISO) Directly Targets Sp1 Protein Translation and Mediates Its Anticancer Activity Both In Vitro and In Vivo.Potential Impact of miR-137 and Its Targets in Schizophrenia.Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancerMicrorna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer.Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancerEating disorder predisposition is associated with ESRRA and HDAC4 mutationsMiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators.MicroRNA-125a reduces proliferation and invasion of oral squamous cell carcinoma cells by targeting estrogen-related receptor α: implications for cancer therapeutics.microRNA-137 modulates pancreatic cancer cells tumor growth, invasion and sensitivity to chemotherapy.MicroRNA-137 upregulation increases bladder cancer cell proliferation and invasion by targeting PAQR3.MicroRNA library-based functional screening identified miR-137 as a suppresser of gastric cancer cell proliferation.Histone modifications induced by MDV infection at early cytolytic and latency phases.Clinical Significance of MiR-137 Expression in Patients with Gastric Cancer After Radical Gastrectomy.miR-135a Inhibits the Invasion of Cancer Cells via Suppression of ERRα.Genomic amplification upregulates estrogen-related receptor alpha and its depletion inhibits oral squamous cell carcinoma tumors in vivoA contrasting function for miR-137 in embryonic mammogenesis and adult breast carcinogenesis.Daidzein-estrogen interaction in the rat uterus and its effect on human breast cancer cell growthERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast CancerGenomic analyses reveal broad impact of miR-137 on genes associated with malignant transformation and neuronal differentiation in glioblastoma cells.miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cellsTargeting estrogen-related receptor alpha inhibits epithelial-to-mesenchymal transition and stem cell properties of ovarian cancer cellsEpigenetic silencing of miR-137 contributes to early colorectal carcinogenesis by impaired Aurora-A inhibition.The orphan nuclear receptors in cancer and diabetes.Estrogen-related receptor alpha and cancer: axis of evil.A New Network-Based Strategy for Predicting the Potential miRNA-mRNA Interactions in Tumorigenesis.MicroRNA-137 chemosensitizes colon cancer cells to the chemotherapeutic drug oxaliplatin (OXA) by targeting YBX1.miR-761 inhibits tumor progression by targeting MSI1 in ovarian carcinoma.miR-137 suppresses the invasion and procedure of EMT of human breast cancer cell line MCF-7 through targeting CtBP1.MicroRNA-137 is downregulated in human osteosarcoma and regulates cell proliferation and migration through targeting FXYD6.MicroRNA-454 functions as an oncogene by regulating PTEN in uveal melanoma.MiR-137: an important player in neural development and neoplastic transformation.Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer.miR-137 effects on gastric carcinogenesis are mediated by targeting Cox-2-activated PI3K/AKT signaling pathway.MiR-137 regulates epithelial-mesenchymal transition in gastrointestinal stromal tumor.Serine-arginine protein kinase 1 is associated with breast cancer progression and poor patient survival.miR-137 impairs the proliferative and migratory capacity of human non-small cell lung cancer cells by targeting paxillin.Tumor-targeting TRAIL expression mediated by miRNA response elements suppressed growth of uveal melanoma cells.miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6.MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.Mcl-1 Is a Novel Target of miR-26b That Is Associated with the Apoptosis Induced by TRAIL in HCC Cells.
P2860
Q30353926-55F93284-EB6B-4500-AC15-666DA334D2D7Q30454963-F5C0DF61-D292-493F-8779-3E9682324774Q30538395-C5641011-5195-4C00-8F66-3210F1205639Q33643578-F78F41E4-BE46-4B16-9CE8-DAD20A248078Q33698278-4862D77B-228F-4F8F-8453-3797EC7717A2Q34384232-30347F65-08E2-464B-A7C3-2C508E1515B1Q34497810-52B6FA08-B940-4573-BCD3-8171962A57C0Q34509860-9AA6A8A6-E2A4-42E2-9E66-7B03771A86D5Q34732990-D869019E-D531-4AFC-8165-0E1B1527A81DQ35350513-A19D20EF-93BE-423D-9BC7-A74963BFD616Q35363689-D9B71D4E-97EF-4D80-9F79-0CBAB58D7F26Q35503432-A887F8B7-8619-438E-916C-A95D52A69D8FQ35834449-73577C9A-C43A-46B0-AE19-AC56E576C4DAQ36030509-2CC3423E-05E2-4FCC-84DA-C1514BA75383Q36350201-1E1506EC-2E60-44DF-83A1-696C3BB0B5F0Q36355868-B063E021-EB21-4E41-9EFE-C012A3327D32Q36469463-288FF321-98B4-456D-848E-F2BC19F50B05Q36693175-E7BBC163-674B-4386-81D5-F3CD29C21AF6Q37505070-BD1126C1-1307-4988-B829-9006176CF24AQ37581142-728BA87E-BB7D-45B6-AD65-BA58730BD5D5Q37696020-B9CF8727-E194-4AAB-9DE2-811A2954C4EBQ37718295-67785A77-92F5-4026-9164-51A0964A4EC1Q38092896-5F370D62-267A-4726-AAE8-3EB7E4877169Q38601908-0A69E9BB-186F-4620-B9E3-F91BFF1AA130Q38613166-47656C88-6DA4-4D5B-80EF-82A569E62285Q38723636-7A7F0470-7C48-48C2-A7F9-1E82A0876669Q38819843-E41B9C27-0FC4-4A95-8D9D-F8B8E5DF1FF9Q38838174-2164CF72-B4EC-4FB4-9259-F4448D629354Q38841251-B3A3762F-E454-47D0-96A6-A356A5C94C13Q38841955-87B5B043-A5D4-46B6-BF76-F64C228D5689Q38952716-3ED5AB8D-0F68-4DA1-ABB8-3B0342DA3F15Q38958559-8FC57D14-4D67-4B89-A6E5-BA0D14CBC427Q38971368-94082C47-4AB1-429A-95C1-BBC41A25D406Q38975057-87EB89D5-165A-4E12-9D3B-7C0BFE186651Q38981645-FC369903-94C4-48D3-8D3E-F14A09ECD1FDQ39062167-59C13D47-0D78-49E7-82F5-C4834596597AQ39100702-CA3E3C09-5C06-4301-BC80-D64737D629D2Q39239384-6E863519-A548-4199-A983-946F6E73A269Q42123071-FA54D5E5-DF02-4B4B-8DD5-C251AEBC9483Q42180490-F6657944-5409-417D-8CF0-C1510282010D
P2860
MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
MiR-137 targets estrogen-relat ...... apacity of breast cancer cells
@ast
MiR-137 targets estrogen-relat ...... apacity of breast cancer cells
@en
MiR-137 targets estrogen-relat ...... apacity of breast cancer cells
@nl
type
label
MiR-137 targets estrogen-relat ...... apacity of breast cancer cells
@ast
MiR-137 targets estrogen-relat ...... apacity of breast cancer cells
@en
MiR-137 targets estrogen-relat ...... apacity of breast cancer cells
@nl
prefLabel
MiR-137 targets estrogen-relat ...... apacity of breast cancer cells
@ast
MiR-137 targets estrogen-relat ...... apacity of breast cancer cells
@en
MiR-137 targets estrogen-relat ...... apacity of breast cancer cells
@nl
P2093
P2860
P1433
P1476
MiR-137 targets estrogen-relat ...... apacity of breast cancer cells
@en
P2093
Fengtian He
Yuanyin Zhao
Zhizhen Xu
P2860
P304
P356
10.1371/JOURNAL.PONE.0039102
P407
P577
2012-06-18T00:00:00Z